Ovarian cancer is the most lethal gynecologic malignancy, with most cases diagnosed at a late stage due to nonspecific symptoms and the lack of effective screening. Evidence indicates that most ovarian cancers originate directly or indirectly from the fallopian tubes, and population-level studies suggest bilateral salpingectomy (removal of the fallopian tubes) can reduce ovarian cancer risk by up to 80 percent.This workshop will examine evidence on the role of the fallopian tubes in ovarian cancer development, the impact of salpingectomy on incidence and mortality, and strategies to address awareness and access barriers and expand its use for ovarian cancer.